Quipt Home Medical Corp T.QIPT

RE:Organic growth

[lscfa]

Analyst see run rate revenue at ~ $250 mil by Sept yearend.

 

$millions US	Sep 23 qtr rev
Stifel	76
Canaccord	62
Raymond James	62
Echelon	63.2
Benchmark	59.4
Leede Jones
Avg. =	64.52

 

lscfa wrote:

Should be closer to 13.6% this year. Run rate revenue = $250 million end of C2023. Quipt revenues are lagging staff increases. Also, GEG has a higher revenue/employee rate than Quipt.

"Organic growth increased by 2% sequentially compared to fiscal Q4 2022. We anticipate organic growth meeting and surpassing historical levels of 8% to 10% as calendar 2023 progresses."
 

"We believe that 8% to 10% in that is probably on the lighter side in that especially when we get into the back half of calendar 2023 between the expansion of the sales force that we're starting to see some impact from and then the full integration in that Great Elm and then supply chain, like we've mentioned, we think at a minimum we can get back to where we were historically prior to supply chain constraints."


 

 

$US 000’s	Revenue	Employees	Rev/avg employee	Payroll	Payroll/avg employee	Payroll/rev
Mar 23 (e)	56,000	1300
Dec 22	40,815	1000	42,963	12,359	13,009	30.3%
Sept 22	40,092	900	47,167	12,455	14,653	31.1%
Jun 22	36,692	800	48,923	10,418	13,891	28.4%
Mar 22	33,553	700	47,933	9,965	14,236	29.7%
Dec 21	29,525	700	42,179	8,618	12,311	29.2%
Sept 21	29,118	700	44,797	8,856	13,625	30.4%
Jun 21	26,238	600		7,257		27.7%